These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 32630493)

  • 1. The Many Faces of Matrix Metalloproteinase-7 in Kidney Diseases.
    Liu Z; Tan RJ; Liu Y
    Biomolecules; 2020 Jun; 10(6):. PubMed ID: 32630493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Matrix metalloproteinase-7 protects against acute kidney injury by priming renal tubules for survival and regeneration.
    Fu H; Zhou D; Zhu H; Liao J; Lin L; Hong X; Hou FF; Liu Y
    Kidney Int; 2019 May; 95(5):1167-1180. PubMed ID: 30878215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix Metalloproteinase-7 Is a Urinary Biomarker and Pathogenic Mediator of Kidney Fibrosis.
    Zhou D; Tian Y; Sun L; Zhou L; Xiao L; Tan RJ; Tian J; Fu H; Hou FF; Liu Y
    J Am Soc Nephrol; 2017 Feb; 28(2):598-611. PubMed ID: 27624489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matrix Metalloproteinase-10 in Kidney Injury Repair and Disease.
    Sun X; Liu Y
    Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urine MMP7 as a kidney injury biomarker.
    Avello A; Guerrero-Mauvecin J; Sanz AB
    Clin Kidney J; 2024 Jan; 17(1):sfad233. PubMed ID: 38186894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tubular injury triggers podocyte dysfunction by β-catenin-driven release of MMP-7.
    Tan RJ; Li Y; Rush BM; Cerqueira DM; Zhou D; Fu H; Ho J; Beer Stolz D; Liu Y
    JCI Insight; 2019 Dec; 4(24):. PubMed ID: 31743113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of matrix metalloproteinase-10 as a key mediator of podocyte injury and proteinuria.
    Zuo Y; Wang C; Sun X; Hu C; Liu J; Hong X; Shen W; Nie J; Hou FF; Zhou L; Liu Y
    Kidney Int; 2021 Oct; 100(4):837-849. PubMed ID: 34175352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD.
    He W; Tan RJ; Li Y; Wang D; Nie J; Hou FF; Liu Y
    J Am Soc Nephrol; 2012 Feb; 23(2):294-304. PubMed ID: 22095947
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Matrix metalloproteinase-10 protects against acute kidney injury by augmenting epidermal growth factor receptor signaling.
    Hu C; Zuo Y; Ren Q; Sun X; Zhou S; Liao J; Hong X; Miao J; Zhou L; Liu Y
    Cell Death Dis; 2021 Jan; 12(1):70. PubMed ID: 33436543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidney Fibrosis and Matrix Metalloproteinases (MMPs).
    La Russa A; Serra R; Faga T; Crugliano G; Bonelli A; Coppolino G; Bolignano D; Battaglia Y; Ielapi N; Costa D; Michael A; Andreucci M
    Front Biosci (Landmark Ed); 2024 May; 29(5):192. PubMed ID: 38812325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix Metalloproteinases-7 and Kidney Fibrosis.
    Ke B; Fan C; Yang L; Fang X
    Front Physiol; 2017; 8():21. PubMed ID: 28239354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Macrophage infiltration and renal damage are independent of matrix metalloproteinase 12 in the obstructed kidney.
    Abraham AP; Ma FY; Mulley WR; Ozols E; Nikolic-Paterson DJ
    Nephrology (Carlton); 2012 May; 17(4):322-9. PubMed ID: 22257277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of matrix metalloproteinase-2 in recovery after tubular damage in acute kidney injury in mice.
    Kaneko T; Shimizu A; Mii A; Fujita E; Fujino T; Kunugi S; Du X; Akimoto T; Tsuruoka S; Ohashi R; Masuda Y; Iino Y; Katayama Y; Fukuda Y
    Nephron Exp Nephrol; 2012; 122(1-2):23-35. PubMed ID: 23548779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wnt/β-catenin signalling and podocyte dysfunction in proteinuric kidney disease.
    Zhou L; Liu Y
    Nat Rev Nephrol; 2015 Sep; 11(9):535-45. PubMed ID: 26055352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships between circulating matrix metalloproteinase-2 and -9 and renal function in patients with chronic kidney disease.
    Chang HR; Yang SF; Li ML; Lin CC; Hsieh YS; Lian JD
    Clin Chim Acta; 2006 Apr; 366(1-2):243-8. PubMed ID: 16313894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of extracellular cleavage of E-cadherin mediated by MMP-7 with HGF-induced in vitro invasion in human stomach cancer cells.
    Lee KH; Choi EY; Hyun MS; Jang BI; Kim TN; Kim SW; Song SK; Kim JH; Kim JR
    Eur Surg Res; 2007; 39(4):208-15. PubMed ID: 17396032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinase-7 induces homotypic tumor cell aggregation via proteolytic cleavage of the membrane-bound Kunitz-type inhibitor HAI-1.
    Ishikawa T; Kimura Y; Hirano H; Higashi S
    J Biol Chem; 2017 Dec; 292(50):20769-20784. PubMed ID: 29046355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IL-13 and TH2 cytokine exposure triggers matrix metalloproteinase 7-mediated Fas ligand cleavage from bronchial epithelial cells.
    Wadsworth SJ; Atsuta R; McIntyre JO; Hackett TL; Singhera GK; Dorscheid DR
    J Allergy Clin Immunol; 2010 Aug; 126(2):366-74, 374.e1-8. PubMed ID: 20624652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpoint.
    Kosugi T; Maeda K; Sato W; Maruyama S; Kadomatsu K
    Nephrol Dial Transplant; 2015 Jul; 30(7):1097-103. PubMed ID: 25248362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syndecan-2 enhances E-cadherin shedding and fibroblast-like morphological changes by inducing MMP-7 expression in colon cancer cells.
    Jang B; Jung H; Chung H; Moon BI; Oh ES
    Biochem Biophys Res Commun; 2016 Aug; 477(1):47-53. PubMed ID: 27270030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.